Adoptive Immunotherapy of Cancer using Activated Autologous Lymphocytes -Current Status and New Strategies-Yoshiyuki Yamaguchi, Tetsuya Toge, Akiko Ohshita et al.|Human Cell|2003Cited by 32
Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.Yoshiyuki Yamaguchi, Tetsuya Toge, Koji Ohta et al.|PubMed|2005Cited by 19
Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironmentYoshiyuki Yamaguchi, Tetsuya Toge, Akiko Ohshita et al.|International Journal of Oncology|2004Cited by 16
HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab.Yoshiyuki Yamaguchi, Tetsuya Toge, Katsuji Hironaka et al.|PubMed|2005Cited by 15
Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patientsAkiko Ohshita, Tetsuya Toge, Yoshiyuki Yamaguchi et al.|International Journal of Oncology|2006Cited by 12